Tinostamustine is an investigational drug with a potential first-in-class mechanism combining bifunctional alkylating activity and pan histone deacetylase (HDAC) inhibition
The new CMC Process R&D Center represents a strategic investment in scale, sustainability, and specialization
New results from telisotuzumab adizutecan (Temab-A) and ABBV-706 demonstrate continued progress in AbbVie's antibody-drug conjugate (ADC) portfolio targeting difficult-to-treat cancers
UZEDY (risperidone) extended-release injectable suspension for subcutaneous use is indicated for use every one or two months for the treatment of schizophrenia in adults
New study presents a human-relevant stress model for assessing potential therapeutics
It represents a 30% increase in the company’s production capacity and introduces a segment dedicated to highly potent active ingredients
Physician-led Pi Health has demonstrated capabilities to dramatically reduce clinical trial timelines and administrative burden, while increasing data quality
Ultra-high purity surfactant for biologics and parenteral drug formulations
Merck and Siemens signed new MoU extending their strategic partnership to accelerate digital transformation in the life science industry
Subscribe To Our Newsletter & Stay Updated
